Taro Pharmaceutical Industries Ltd (NYSE:TARO)

143.22
Delayed Data
As of Mar 27
 +1.22 / +0.86%
Today’s Change
102.72
Today|||52-Week Range
173.00
-3.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2012

2013

2014
Revenue and IncomeNet Revenues392.5M580.6M671.0M759.3M
 
 
 
 
 
Cost of Goods Sold140.2M165.5M158.4M162.7M
 
 
 
 
 
Depreciation And Amortization18.8M18.4M17.8M16.6M
 
 
 
 
 
 
Operating ExpensesGross Income233.5M396.7M494.8M580.0M
 
 
 
 
 
General Expenses144.3M131.8M132.9M147.2M
 
 
 
 
 
Other Operating Expenses0.004.4M0.000.00
 
 
Research And Development36.4M39.4M46.5M55.4M
 
 
 
 
 
Total Operating Expenses303.3M320.1M309.1M326.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income89.2M260.5M361.9M432.8M
 
 
 
 
 
Extraordinary Credit0.00364.0K--0.00
 
 
Extraordinary Charge-2.7M---33.3M-2.6M
 
 
 
 
Interest Expense On Debt7.5M68.9M19.3M18.3M
 
 
 
 
 
Other Expenses-4.5M-740.0K5.8M8.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income75.4M260.5M335.9M443.9M
 
 
 
 
 
Income Taxes-10.5M-71.2M-67.8M-82.7M
 
 
 
 
 
Minority Interest-473.0K-604.0K-664.0K-472.0K
 
 
 
 
 
Discontinued Operations-352.0K264.0K-1.2M-319.0K
 
 
 
 
 
Net Income64.1M189.0M266.2M360.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.3M44.5M44.7M44.3M
 
 
 
 
 
Shares To Calculate EPS Diluted41.9M44.6M44.7M44.3M
 
 
 
 
 
 
Earnings Per ShareEPS$1.59$1.06$5.96$8.14
 
 
 
 
 
EPS Diluted$1.53$4.24$5.95$8.14
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account